MDM2–MOF–H4K16ac axis contributes to tumorigenesis induced by Notch

  title={MDM2–MOF–H4K16ac axis contributes to tumorigenesis induced by Notch},
  author={Y. Liu and Zhao-bin Xing and Shu-qing Wang and Su Chen and Yan-kun Liu and Yu-Hui Li and Yu-Feng Li and Ya-qi Wang and Y. Lu and Wan-ning Hu and Jing-Hua Zhang},
  journal={The FEBS Journal},
Identification of the epigenetic mechanisms involved in the transmission of Notch signaling is useful for personalized medicine. We observed that aberrantly high levels of Notch activity resulted in H4K16ac downregulation in hepatocellular carcinoma and breast cancer cell lines and tissues. This downregulated acetylation was a consequence of increased male on the first degradation following the upregulation of full‐length murine double minute 2 in different cancer types. We observed that… Expand
Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers
This review summary summarizes the general epigenetic mechanisms in cancer, including: the post-translational modification of DNA methyltransferase and its mediated inactivation of Ras association domain family 1 isoform A, Sonic hedgehog signaling, Wnt signaling, Notch signaling, transforming growth factor signaling, and natural products with epigenetic modification ability, and the importance of nanomedicine for delivery of natural Products with modulating ability to epigenetic machinery in cancer cells. Expand
MDM2 Contributes to High Glucose-Induced Glomerular Mesangial Cell Proliferation and Extracellular Matrix Accumulation via Notch1
A pivotal role of MDM2 is proposed in high glucose-induced GMC proliferation and ECM accumulation, via modulating the activation of Notch1 signaling pathway in an ubiquitination-dependent way. Expand
Activation of KRas‐ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16
The results suggest that activation of KRas‐ERK1/2 signaling participates in the onset and progression of glioma at least partially through modulating acetylation of H4 at K16. Expand
WSTF acetylation by MOF promotes WSTF activities and oncogenic functions
An acetylation-dependent mechanism that modulates the activities of WSTF and contributes to tumorigenesis is demonstrated that promotes cancer cell proliferation, migration, invasion, and tumor formation. Expand
Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma.
It is proved it was histone hypoacetylation rather than DNA hypermethylation that participated in transcriptional repression of OAT2 in two HCC cell lines and the results demonstrated that SAHA could sensitize HCC cells to 5-FU. Expand
Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
Sequential combination of cisplatin prior to MK-0752 significantly promoted cell apoptosis and inhibited the subcutaneous xenograft growth of ovarian cancer in nude mice, indicating a highly promising novel experimental therapeutic strategy against ovarian cancer. Expand
KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway
A new pathway is identified that Williams–Beuren syndrome transcription factor (WSTF), a non-secretory protein, was released in complex with secretory protein-neuregulin-3 (NRG3), which activates the transcription of NRG3 and promotes the formation of colon tumors. Expand
Dysregulation of intercellular signaling by MOF deletion leads to liver injury
It is reported that MOF plays an essential role in adult liver and the in vitro coculturing experiment shows that Mof deletion-induced liver injury requires coordinated changes and reciprocal signaling between hepatocytes and Kupffer cells, which enables feedforward regulation to augment inflammation and apoptotic responses. Expand
Histone variant H3.3 orchestrates neural stem cell differentiation in the developing brain
RNA-seq data show the GLI1, a transcriptional regulator, is downregulated in H3.3 knockdown NSCs, and cooperates with MOF to increase the level of the H4K16ac and the GLi1, and then regulates the N SCs proliferation and differentiation. Expand
Investigation of epigenetic regulators important for tumour initiation and maintenance
This paper aims to provide a chronology of the events leading to and following the publication of the book and some of the key events that led to its publication. Expand


Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
The transcriptional regulator YAP up-regulates Jag-1 to activate Notch signaling in HCC cells and mouse hepatocytes, suggesting the use of YAP and Notch inhibitors as therapeutics for gastrointestinal cancer. Expand
Notch1 binds and induces degradation of Snail in hepatocellular carcinoma
This study demonstrates that Notch1 intracellular domain (NICD) can oppose Snail-dependent HCC cell invasion by binding and inducing proteolytic degradation of Snail. Expand
Targeting deregulated epigenetic control in cancer
In this review, the various aspects of epigenetic control that are operative in a variety of cancers and their potential for risk assessment, early detection, targeted therapy, and personalized medicine are discussed. Expand
Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway.
MDM2 can synergize with Notch1 to inhibit apoptosis and promote proliferation and makes MDM2 an attractive target for drug discovery for both the p53 and Notch signalling pathways. Expand
Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis
High level expression of Notch receptors and ligands, and its increased activation in several breast cancers and early precursors, places Notch signaling as a key player in breast cancer pathogenesis. Expand
IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression.
A TNFα/IKKα/FOXA2/NUMB/ NUMB/NOTCH1 pathway that is critical for inflammation-mediated tumorigenesis and may provide a target for clinical intervention in human cancer is reported. Expand
Notch signaling and breast cancer.
  • M. Reedijk
  • Biology, Medicine
  • Advances in experimental medicine and biology
  • 2012
Evidence continues to accumulate that aberrant Notch activity influences breast cancer progression through these processes. Expand
Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.
It is found that Notch1 signaling retained the capability of suppressing the expression of WNT target genes in colorectal cancers even when β-catenin destruction by the adenomatous polyposis coli (APC) complex was disabled. Expand
Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway
It was found that HBx upregulated the expression of Notch-1, Jagged-1 and Hes-1 at the transcriptional level by binding to the NotCh-1 intracellular domain, which is congruent with the observations of enhanced malignant biological activities of HBx-transfected HepG2 cells compared with normal HepG 2 cells. Expand
The Down-Regulation of Notch1 Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Inactivating the Cyclooxygenase-2/Snail/E-cadherin Pathway In Vitro
Down-regulated Notch1 may be an effective approach to inactivating Snail/E-cadherin by regulating COX-2, which results in inhibiting the invasion and migration of HCC cells. Expand